These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9570348)

  • 1. The role of angiogenesis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas.
    Ozer E; Canda T; Kurtodlu B
    Cancer Lett; 1997 Dec; 121(2):119-23. PubMed ID: 9570348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
    Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
    Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
    Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
    Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
    Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
    Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.
    Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D
    World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast.
    Şener E; Şipal S; Gündoğdu C
    Turk Patoloji Derg; 2016; 32(3):164-70. PubMed ID: 27562390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.
    Regidor PA; Callies R; Regidor M; Günthert U; Zöller M; Schindler AE
    Arch Gynecol Obstet; 1996; 258(3):125-35. PubMed ID: 8781700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer.
    Schneider J; Pollán M; Ruibal A; Jiménez E; Lucas AR; Núñez MI; Sánchez J; Tejerina A
    Tumour Biol; 1999; 20(6):319-30. PubMed ID: 10567878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between lymphatic metastasis in breast and cervix cancers and the level of CD44-H expression evaluated by an immunohistochemical method].
    Yahyaoui O; Guerbaoui M; Oudghiri M
    Gynecol Obstet Fertil; 2001 Jun; 29(6):422-6. PubMed ID: 11462957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
    Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
    Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.
    Schumacher U; Horny HP; Horst HA; Herrlich P; Kaiserling E
    Eur J Surg Oncol; 1996 Jun; 22(3):259-61. PubMed ID: 8654608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
    J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer.
    Gasparini G; Barbareschi M; Boracchi P; Bevilacqua P; Verderio P; Dalla Palma P; Ménard S
    Int J Cancer; 1995 Mar; 60(5):604-10. PubMed ID: 7860133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvessel quantitation and prognosis in invasive breast carcinoma.
    Bosari S; Lee AK; DeLellis RA; Wiley BD; Heatley GJ; Silverman ML
    Hum Pathol; 1992 Jul; 23(7):755-61. PubMed ID: 1377162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosol concentrations of CD44 isoforms in breast cancer tissue.
    Hefler L; Tempfer C; Haeusler G; Kucera E; Mayerhofer K; Zeillinger R; Reinthaller A; Kainz C
    Int J Cancer; 1998 Oct; 79(5):541-5. PubMed ID: 9761127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
    Shrivastav S; Bal A; Singh G; Joshi K
    Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between laminin and type IV collagen distribution in breast carcinomas, and estrogen receptors expression, lymph node and vascular involvement.
    Charpin C; Andrac L; Habib MC; Vacheret H; Lavaut MN; Xerri L; Figarella-Branger D; Casanova P; Toga M
    Med Oncol Tumor Pharmacother; 1990; 7(1):43-54. PubMed ID: 2187122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are CD44
    Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
    Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer.
    Ozer E; Mungan MU; Tuna B; Kazimoğlu H; Yörükoğlu K; Kirkali Z
    Urology; 1999 Jul; 54(1):50-5. PubMed ID: 10414726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.